Related Experiment Video
Updated: Jan 21, 2026

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
Published on: October 20, 2015
[Indirubin inhibits the proliferation of prostate cancer PC-3 cells]
Objective:
To explore the antitumoral effect of indirubin on androgen-independent prostate cancer PC-3 cells and its possible mechanisms.
Methods:
We measured the inhibitory effect of indirubin on the proliferation of prostate cancer PC-3 cells using MTT assay, detected their cell cycles by flow cytometry, and determined the expressions of the cell cycle regulatory protein cyclin D1 and its related downstream gene c-myc by Western blot.
Results:
The viability of the PC-3 cells was significantly decreased by indirubin in a concentration-dependent manner, reduced to 52. 2% and 13. 6% at 5 and 10 µmol/L, respectively. The cell cycle of the PC-3 cells was markedly inhibited by indirubin at 5 µmol/L, with the cells remarkably increased in the G0 and G1 phases and decreased in the S and G2/M phases. Meanwhile, indirubin also inhibited the expressions of cyclin D1 and c-myc in the Wnt signaling pathway.
Conclusion:
Indirubin can suppress the proliferation of androgen-independent prostate cancer PC-3 cells, which may be associated with its inhibitory effect on the cell cycle and Wnt signaling pathway.
Insights
Indirubin significantly inhibits prostate cancer PC-3 cell proliferation by disrupting the cell cycle and Wnt signaling pathway. This study explores indirubin
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Prostate cancer remains a significant health concern, particularly androgen-independent forms.
- PC-3 cells represent a model for aggressive, treatment-resistant prostate cancer.
- Understanding novel therapeutic agents is crucial for advancing prostate cancer treatment.
Purpose of the Study:
- To investigate the antitumoral effects of indirubin on androgen-independent prostate cancer PC-3 cells.
- To elucidate the underlying mechanisms, focusing on cell cycle regulation and Wnt signaling.
Main Methods:
- MTT assay to assess cell proliferation inhibition.
- Flow cytometry to analyze cell cycle distribution.
- Western blot to determine protein expression of cyclin D1 and c-myc.
Main Results:
- Indirubin reduced PC-3 cell viability in a dose-dependent manner.
- Indirubin induced G0/G1 phase arrest and reduced S/G2/M phase populations.
- Indirubin suppressed the expression of cyclin D1 and c-myc within the Wnt signaling pathway.
Conclusions:
- Indirubin demonstrates potent antiproliferative activity against androgen-independent prostate cancer PC-3 cells.
- The observed effects are linked to indirubin's ability to inhibit cell cycle progression.
- Indirubin's impact on the Wnt signaling pathway is a key mechanism contributing to its antitumoral effects.
Related Concept Videos
Enzyme Inhibition
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Inhibition of Cdk Activity
Cancer Cell Migration through Invadopodia

